Cogenics Adopts NuGEN Ovation® Systems
News Nov 15, 2007
The Ovation Systems family of RNA amplification and labeling products empower life scientists to conduct sensitive gene expression profiling and signature discovery using sample types as diverse as whole blood, fresh tissue biopsies, laser-captured micro-dissected cells (LCM), sorted cells, and FFPE (formalin-fixed, paraffinembedded) tissue.
Cogenics will offer target preparation services using three Ovation Systems, enabling scientists to unlock biological secrets that lie within recent biological specimens, as well as the millions of samples collected and banked through years of clinical research. They include: Ovation™ Whole Blood Solution, WT-Ovation™ Pico System, T-Ovation™ FFPE System.
“NuGEN’s Ovation Systems are a great match for our services,” said Clive Higgins, general manager of Cogenics. “A large number of our customers are investigating challenging clinical samples using the Affymetrix GeneChip platform. With NuGEN’s excellent amplification technology, we can help them detect extremely lowabundance transcripts in severely limited or compromised samples. Our solution can salvage countless samples and years of valuable research in which they’ve invested.”
With NuGEN’s Ovation system, just picograms of total RNA from precious RNA samples can yield micrograms of amplified cDNA that can be fragmented and labeled for same-day hybridization to Affymetrix GeneChip arrays for global gene expression analysis.
Genome-wide association studies (GWAS) look at large populations to find genes that contribute to common, multi-gene traits like height or obesity. These comprehensive studies frequently turn up large numbers of tiny genetic variations that occur more often in people who are tall, obese, etc. So which genes should scientists investigate further?READ MORE
In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.